| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 7,555 | $0.36 | $2,753.04 | -1.4% | +9.0% | +49.1% | |
| Feb 20, 2024 | AORT Artivion, Inc. | Maney Rochelle L. | VP, Quality | Sell | 407 | $18.87 | $7,678.05 | -1.4% | +27.3% | +57.0% | |
| Feb 20, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 28,282 | $0.36 | $10,093.85 | -1.6% | +9.0% | +49.1% | |
| Feb 20, 2024 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 3,527 | $18.87 | $66,536.86 | -0.9% | +27.3% | +57.0% | |
| Feb 20, 2024 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 2,556 | $18.87 | $48,218.94 | -1.0% | +27.3% | +57.0% | |
| Feb 20, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 22,625 | $0.36 | $8,242.29 | -1.8% | +9.0% | +49.1% | |
| Feb 20, 2024 | AORT Artivion, Inc. | Getz Matthew A | VP, Human Resources | Sell | 1,695 | $18.87 | $31,976.18 | -2.9% | +27.3% | +57.0% | |
| Feb 20, 2024 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 23,958 | $2.96 | $70,915.68 | -1.6% | -16.5% | +47.2% | |
| Feb 20, 2024 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,695 | $18.87 | $31,976.18 | -0.7% | +27.3% | +57.0% | |
| Feb 20, 2024 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 3,363 | $116.73 | $392,562.99 | -4.5% | +10.9% | -23.9% | |
| Feb 20, 2024 | AORT Artivion, Inc. | Tyrs Florian | VP, Global Operations | Sell | 249 | $18.87 | $4,697.38 | -1.5% | +27.3% | +57.0% | |
| Feb 20, 2024 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 72,069 | $18.85 | $1,358,817.68 | -4.2% | +27.3% | +57.0% | |
| Feb 20, 2024 | PACB Pacific Biosciences Of California, Inc. | Henry Christian O78 | See Remarks | Sell | 81,017 | $5.94 | $481,319.92 | -3.9% | -63.7% | -66.5% | |
| Feb 20, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 3,108 | $90.00 | $279,720.00 | -9.8% | +56.4% | -10.4% | |
| Feb 20, 2024 | PACB Pacific Biosciences Of California, Inc. | Kim Susan G.77 | See Remarks | Sell | 23,327 | $5.93 | $138,403.06 | -4.0% | -63.7% | -66.5% | |
| Feb 20, 2024 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 13,662 | $65.86 | $899,779.32 | -4.8% | +13.8% | +59.6% | |
| Feb 16, 2024 | OWLT Owlet, Inc. | Scolnick Kathryn R.69 | Chief Financial Officer | Sell | 334 | $4.46 | $1,489.64 | -0.3% | -10.5% | +9.9% | |
| Feb 16, 2024 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 7,562 | $5.96 | $45,054.40 | -7.0% | -61.8% | -67.8% | |
| Feb 16, 2024 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 38,587 | $20.96 | $808,590.59 | -1.0% | -27.7% | -21.7% | |
| Feb 16, 2024 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 4,160 | $20.96 | $87,172.80 | -3.2% | -27.7% | -21.7% | |
| Feb 16, 2024 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 7,336 | $20.96 | $153,725.88 | -0.9% | -27.7% | -21.7% | |
| Feb 16, 2024 | HYPR Hyperfine, Inc. | Teisseyre Thomas60 | Chief Operating Officer | Sell | 3,230 | $1.11 | $3,585.30 | -3.2% | -24.2% | +8.1% | |
| Feb 16, 2024 | PACB Pacific Biosciences Of California, Inc. | Eidel Jeff76 | See Remarks | Sell | 15,498 | $5.96 | $92,337.08 | -3.5% | -61.8% | -67.8% | |
| Feb 16, 2024 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 33,560 | $5.96 | $199,950.48 | -3.7% | -61.8% | -67.8% | |
| Feb 16, 2024 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 7,822 | $20.96 | $163,910.01 | -0.6% | -27.7% | -21.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.